GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Cyclically Adjusted Price-to-FCF

Senzime AB (OSTO:SEZI) Cyclically Adjusted Price-to-FCF : (As of Jun. 09, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Senzime AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Senzime AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Cyclically Adjusted Price-to-FCF Chart

Senzime AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Senzime AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Senzime AB's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Senzime AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senzime AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Senzime AB's Cyclically Adjusted Price-to-FCF falls into.



Senzime AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Senzime AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Senzime AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.276/132.2054*132.2054
=-0.276

Current CPI (Mar. 2024) = 132.2054.

Senzime AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.140 100.432 -0.184
201409 -0.112 100.161 -0.148
201412 -0.186 100.225 -0.245
201503 -0.149 99.950 -0.197
201506 -0.252 99.995 -0.333
201509 -0.126 100.228 -0.166
201512 -0.170 100.276 -0.224
201603 -0.153 100.751 -0.201
201606 -0.132 101.019 -0.173
201609 -0.157 101.138 -0.205
201612 -0.143 102.022 -0.185
201703 -0.170 102.022 -0.220
201706 -0.131 102.752 -0.169
201709 -0.143 103.279 -0.183
201712 -0.147 103.793 -0.187
201803 -0.150 103.962 -0.191
201806 -0.154 104.875 -0.194
201809 -0.168 105.679 -0.210
201812 -0.227 105.912 -0.283
201903 -0.239 105.886 -0.298
201906 -0.110 106.742 -0.136
201909 -0.107 107.214 -0.132
201912 -0.147 107.766 -0.180
202003 -0.124 106.563 -0.154
202006 -0.154 107.498 -0.189
202009 -0.135 107.635 -0.166
202012 -0.257 108.296 -0.314
202103 -0.285 108.360 -0.348
202106 -0.377 108.928 -0.458
202109 -0.320 110.338 -0.383
202112 -0.343 112.486 -0.403
202203 -0.293 114.825 -0.337
202206 -0.392 118.384 -0.438
202209 -0.968 122.296 -1.046
202212 -0.439 126.365 -0.459
202303 -0.485 127.042 -0.505
202306 -0.367 129.407 -0.375
202309 -0.272 130.224 -0.276
202312 -0.256 131.912 -0.257
202403 -0.276 132.205 -0.276

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Senzime AB  (OSTO:SEZI) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Senzime AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Senzime AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Senzime AB (OSTO:SEZI) Business Description

Traded in Other Exchanges
Address
Ulls vag 41, Uppsala, SWE, 756 51
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Senzime AB (OSTO:SEZI) Headlines

No Headlines